CELU Stock Analysis: Buy, Sell, or Hold?
CELU - Celularity Inc. Class A Common Stock
$1.22
-0.05 (-3.71%)
▼
5d:
-5.43%
30d:
+8.44%
90d:
-36.79%
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Dec 05, 2025
0d
Get Alerted When CELU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CELU shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CELU shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CELU is currently trading at $1.22, which is considered slightly low relative to its 30-day fair value range of $1.21 to $1.32.
Technical Outlook: Technically, CELU is in a strong downtrend. The price is currently testing key support at $1.19. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.50 (+104.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CELU is in a strong downtrend. The price is currently testing key support at $1.19. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.50 (+104.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.21 -
$1.32
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding CELU? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.7%)
- BULLISH: Trading 104.9% below Wall St target ($2.50)
- CAUTION: Recommendation downgraded due to -5.4% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.21 -
$1.32
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.19
Resistance Level
$1.37
Current Trend
Strong Downtrend
Fundamental Context
Wall Street Target
$2.50
(+104.9%)
Revenue Growth (YoY)
-43.2%
Earnings Growth (YoY)
-61.3%
Profit Margin
-198.8%
Last updated: February 02, 2026 4:33 AM ET
Data refreshes hourly during market hours. Next update: 5:33 AM
Data refreshes hourly during market hours. Next update: 5:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
Advanced CELU Option Strategies
Professional options setups generated by AI based on today's CELU price and gamma walls.
